4//SEC Filing
Taylor Stacy L 4
Accession 0001062993-24-015606
CIK 0001478320other
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:27 PM ET
Size
5.4 KB
Accession
0001062993-24-015606
Insider Transaction Report
Form 4
Taylor Stacy L
SVP and General Counsel
Transactions
- Sale
Common Stock
2024-08-22$4.50/sh−26,922$121,079→ 139,365 total
Footnotes (2)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 23, 2024.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $4.415 to $4.62, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001799081
Filing Metadata
- Form type
- 4
- Filed
- Aug 22, 8:00 PM ET
- Accepted
- Aug 23, 4:27 PM ET
- Size
- 5.4 KB